The whole subject of genetics may be viewed as a controversial topic. This is largely due to other aspects of the science, such as cloning, eugenics and stem cell research, which do not include pharmacogenetics.

PGXIS has years of experience in writing consent forms and responding to any queries from ethical review bodies around the world.

The result is that pharmacogenomic studies are implemented with protection of participants interests and without delay to the clinical study.